Selegiline Transdermal System: In the Treatment of Major Depressive DisorderA Viewpoint by J. Alexander Bodkin

被引：0

作者：

J. Alexander Bodkin

机构：

[1] Harvard Medical School,Consolidated Department of Psychiatry

来源：

Drugs | 2007年 / 67卷 / 2期

关键词：

D O I：

10.2165/00003495-200767020-00007

中图分类号：

学科分类号：

摘要：

引用

页码：266 / 266

共 50 条

[21] Treatment Patterns among US Veterans Treated with Selegiline Transdermal System
DuVall, Scott L.
Portland, Kimberly B.
Painter, Terry
Wilson, Andrew
Agbor, Stephen
Kamauu, Aaron W. C.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 35 - 35
[22] Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
Carlat, Daniel J.
PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (03) : 29 - 31
[23] Selegiline transdermal system for the treatment of major depressive disorder: An 8-week, double-blind, placebo-controlled, flexible-dose titration trial
Feiger, Alan D.
Rickels, Karl
Rynn, Moira A.
Zimbroff, Dan L.
Robinson, Donald S.
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (09) : 1354 - 1361
[24] Transdermal Scopolamine for Treatment-Resistant Major Depressive Disorder
Liester, Mitchell B.
Shash, Delia S.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
[25] Selegiline transdermal system in major depressive disorder - Profile report (Reprinted from Drugs, vol 67, pg 257-267, 2007)
Frampton, James E.
Plosker, Greg L.
CNS DRUGS, 2007, 21 (06) : 521 - 524
[26] The pressor effects of oral tyramine following treatment with the selegiline-transdermal system
Blob, LF
Azzaro, AJ
Kemper, EM
Campbell, BJ
VanDenBerg, CM
BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 152S - 152S
[27] A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder
Amsterdam, JD
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (02) : 208 - 214
[28] Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)
Jang, Saeheon
Jung, Sungwon
Pae, Chiun
Portland, Kimberly Blanchard
Nelson, J. Craig
Patkar, Ashwin A.
JOURNAL OF AFFECTIVE DISORDERS, 2013, 151 (03) : 854 - 859
[29] Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): A comparison with oral selegiline capsules
Azzaro, Albert J.
Ziemniak, John
Kemper, Eva
Campbell, Bryan J.
VanDenBerg, Chad
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (10): : 1256 - 1267
[30] Antidepressant Treatment and Risk of Suicide Attempt by Adolescents with Major Depressive DisorderA Propensity-Adjusted Retrospective Cohort Study
Robert J. Valuck
Anne M. Libby
Marion R. Sills
Alexis A. Giese
Richard R. Allen
CNS Drugs, 2004, 18 : 1119 - 1132

← 1 2 3 4 5 →